AARD Aardvark Therapeutics, Inc.

Fundamentals / CIK 0001774857 / USD

Aardvark Therapeutics, Inc. reported $0 in revenue and a net loss of $72.76M for the trailing twelve months ended September 30, 2026.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open AARD in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

2 fiscal years (2024 to 2025), reported in USD.

$0$0$0-$53.85MFY 2024 Net Income: -$20.59M2024FY 2025 Revenue: $0FY 2025 Net Income: -$57.59M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31
Revenue $0 --
Research & Development $48.94M $17.36M
Total Operating Expenses $62.73M $22.79M
Operating Income -$62.73M -$22.79M
EBITDA -$62.69M -$22.77M
Interest Income $5.14M $2.41M
Income Tax Expense $0 $0
Net Income -$57.59M -$20.59M
Basic EPS -$24.83 -$43.64
Diluted EPS -$24.83 -$43.64
Basic Shares Outstanding 2.3M 471.6K
Diluted Shares Outstanding 2.3M 471.6K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $0 $0 $0 $0 $0 --
Research & Development $15.67M $10.46M $16.57M $14.30M $13.74M $13.14M $7.75M $8.06M
Total Operating Expenses $19.72M $15.08M $22.46M $18.70M $17.70M $15.85M $10.47M $9.45M
Operating Income -$19.72M -$15.08M -$22.46M -$18.70M -$17.70M -$15.85M -$10.47M -$9.45M
EBITDA -$19.71M -$15.07M -$22.45M -$18.69M -$17.69M -$15.84M -$10.46M -$9.44M
Interest Income $539K $695K $889K $1.12M $1.35M $1.49M $1.18M $717K
Net Income -$19.19M -$14.39M -$21.59M -$17.60M -$16.32M -$14.37M -$9.31M -$8.78M
Basic EPS -$0.88 -$0.66 -$8.39 -- -$0.75 -$0.66 -$6.02 --
Diluted EPS -$0.88 -$0.66 -$8.39 -- -$0.75 -$0.66 -$6.02 --
Basic Shares Outstanding 21.9M 21.8M 2.6M -- 21.7M 21.7M 1.6M --
Diluted Shares Outstanding 21.9M 21.8M 2.6M -- 21.7M 21.7M 1.6M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31
Cash & Cash Equivalents $47.05M $61.64M
Short-Term Investments $62.98M $12.02M
Cash & Short-Term Investments $110.0M $73.66M
Total Current Assets $111.9M $74.14M
Other Non-Current Assets $4.94M $2.63M
Total Non-Current Assets $5.29M $3.37M
Total Assets $117.2M $77.51M
Accounts Payable $2.07M $2.30M
Total Current Liabilities $10.55M $4.93M
Other Non-Current Liabilities $0 $26K
Total Non-Current Liabilities $0 $467K
Total Liabilities $10.55M $5.39M
Total Debt (incl. Leases) $441K $779K
Common Stock $0 $0
Retained Earnings -$115.9M -$58.33M
Accumulated Other Comp. Income $81K $0
Total Stockholders' Equity $106.6M -$54.64M
Total Equity $106.6M -$54.64M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $60.34M $73.85M $62.44M $47.05M $39.28M $26.00M $26.50M $61.64M
Short-Term Investments $13K $21K $28.76M $62.98M $87.06M $115.8M $124.8M $12.02M
Cash & Short-Term Investments $60.30M $73.90M $91.20M $110.0M $126.4M $141.8M $151.3M $73.66M
Total Current Assets $64.11M $80.66M $93.58M $111.9M $129.2M $144.8M $154.6M $74.14M
Other Non-Current Assets $162K $173K $4.74M $4.94M $3.58M $2.19M $1.84M $2.63M
Total Non-Current Assets $694K $799K $5.01M $5.29M $4.02M $2.71M $2.47M $3.37M
Total Assets $64.80M $81.46M $98.59M $117.2M $133.2M $147.5M $157.0M $77.51M
Accounts Payable $1.59M $2.09M $4.49M $2.07M $4.44M $5.06M $2.56M $2.30M
Total Current Liabilities $7.03M $6.39M $11.60M $10.55M $10.74M $10.31M $5.98M $4.93M
Other Non-Current Liabilities -- -- -- $0 $0 $12K $24K $26K
Total Non-Current Liabilities $159K $276K $0 $0 $116K $240K $360K $467K
Total Liabilities $7.19M $6.66M $11.60M $10.55M $10.85M $10.55M $6.34M $5.39M
Total Debt (incl. Leases) $572K $677K $336K $441K $545K $645K $726K $779K
Common Stock $0 $0 $0 $0 $0 $0 $0 $0
Retained Earnings -$171.1M -$151.9M -$137.5M -$115.9M -$98.32M -$82.00M -$67.64M -$58.33M
Accumulated Other Comp. Income $0 $0 $14K $81K $82K -$3.0K $44K $0
Total Stockholders' Equity $57.61M $74.80M $86.99M $106.6M $122.4M $136.9M $150.7M -$54.64M
Total Equity $57.61M $74.80M $86.99M $106.6M $122.4M $136.9M $150.7M -$54.64M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31
Net Income -$57.59M -$20.59M
Depreciation & Amortization $36K $16K
Stock-Based Compensation $3.95M $439K
Change in Payables $239K $798K
Operating Cash Flow -$54.17M -$18.09M
Capital Expenditure -$95K -$109K
Free Cash Flow -$54.27M -$18.20M
Investing Cash Flow -$49.67M -$12.00M
Common Stock Issued $195K $0
Financing Cash Flow $89.25M $81.99M
Net Change in Cash -$14.59M $51.91M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$19.19M -$14.39M -$21.59M -$17.60M -$16.32M -$14.37M -$9.31M -$8.78M
Depreciation & Amortization $10K $11K $11K $10K $10K $11K $5.0K $8.0K
Stock-Based Compensation $1.97M $1.95M $2.00M $1.58M $1.50M $634K $233K $173K
Change in Payables -$497K -$2.41M $2.42M -$2.37M -$612K $2.58M $648K $1.19M
Operating Cash Flow -$13.54M -$17.60M -$18.87M -$16.81M -$16.13M -$9.84M -$11.39M -$7.73M
Capital Expenditure -- -- -- $0 -$4.0K -$91K $0 -$6.0K
Free Cash Flow -- -- -- -$16.81M -$16.13M -$9.94M -$11.39M -$7.73M
Investing Cash Flow $0 $28.75M $34.25M $24.30M $29.25M $9.41M -$112.6M -$11.89M
Financing Cash Flow $22K $262K $4.0K $274K $171K -$71K $88.88M -$1.01M
Net Change in Cash -$13.51M $11.41M $15.38M $7.77M $13.29M -$506K -$35.14M -$20.64M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31
Return on Equity (ROE) -54.0% --
Return on Assets (ROA) -49.1% -26.6%
Current Ratio 10.61x 15.05x
Quick Ratio 10.43x 14.95x
Debt to Equity 0.00x --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -126.3% -93.4% -80.3% -54.0% -39.9% -26.8% -18.4% --
Return on Assets (ROA) -112.3% -85.8% -70.9% -49.1% -36.6% -24.8% -17.7% -26.6%
Current Ratio 9.11x 12.63x 8.06x 10.61x 12.03x 14.04x 25.86x 15.05x
Quick Ratio 8.57x 11.57x 7.86x 10.43x 11.77x 13.75x 25.32x 14.95x
Debt to Equity 0.01x 0.01x 0.00x 0.00x 0.00x 0.00x 0.00x --
Source: SEC EDGAR CompanyFacts (CIK 0001774857) · from March 31, 2024 Data through September 30, 2026 · synced Nov 21, 2026, 05:02 UTC · Open in terminal